CU22666A1 - PROCEDURE FOR THE EXPRESSION OF GENES OF DENGUE VIRUSES IN PICHIA PASTORIS LEAVE, RECOMBINANT ADNS AND TRANSFORMED MICROORGANISMS - Google Patents
PROCEDURE FOR THE EXPRESSION OF GENES OF DENGUE VIRUSES IN PICHIA PASTORIS LEAVE, RECOMBINANT ADNS AND TRANSFORMED MICROORGANISMSInfo
- Publication number
- CU22666A1 CU22666A1 CU1996107A CU1996107A CU22666A1 CU 22666 A1 CU22666 A1 CU 22666A1 CU 1996107 A CU1996107 A CU 1996107A CU 1996107 A CU1996107 A CU 1996107A CU 22666 A1 CU22666 A1 CU 22666A1
- Authority
- CU
- Cuba
- Prior art keywords
- dengue
- expression
- virus
- recombinant
- adns
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 241000710829 Dengue virus group Species 0.000 title abstract 2
- 241000235058 Komagataella pastoris Species 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 208000001490 Dengue Diseases 0.000 abstract 3
- 206010012310 Dengue fever Diseases 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 3
- 208000025729 dengue disease Diseases 0.000 abstract 3
- 241000725619 Dengue virus Species 0.000 abstract 1
- 101710091045 Envelope protein Proteins 0.000 abstract 1
- 101710204837 Envelope small membrane protein Proteins 0.000 abstract 1
- 241000235648 Pichia Species 0.000 abstract 1
- 101710188315 Protein X Proteins 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 101710088839 Replication initiation protein Proteins 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 208000009714 Severe Dengue Diseases 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24161—Methods of inactivation or attenuation
- C12N2710/24162—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se relaciona con la rama de la biotecnología y con las técnicas de ADN recombinante y en particular con un procedimiento para la expresión del gen que codifica para la proteína de la envoltura de los virus del dengue seropositivos 2 y 4 en levaduras metilotróficas del genero Pichia. El objetivo es obtener un inmunógeno para vacunación en humanos. Para el virus dengue serotipo 2 se partió de la secuencia génica que codifica para la peoteína E del virus, a partir de la cepa A 15 aislada durante la epidemia de fiebre del dengue y dengue hemorrágico ocurrida en Cuba en el ano 1981. En el caso del virus Dengue serotipo 4 se partió de la secuencia génica que codifica para la proteína E del virus, a partir de la cepa 814669 aislada durante la epidemia de fiebre del dengue ocurrida en Dominica en el ano 1981.The present invention relates to the biotechnology branch and to recombinant DNA techniques and in particular to a method for the expression of the gene that encodes the envelope protein of seropositive dengue viruses 2 and 4 in methylotrophic yeasts of the genus Pichia. The goal is to obtain an immunogen for vaccination in humans. For the dengue serotype 2 virus, it was based on the gene sequence coding for the peotein E of the virus, from strain A 15 isolated during the dengue fever and hemorrhagic dengue fever epidemic that occurred in Cuba in 1981. In the case Dengue virus serotype 4 was based on the gene sequence that codes for the protein E of the virus, from strain 814669 isolated during the dengue fever epidemic that occurred in Dominica in 1981.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU1996107A CU22666A1 (en) | 1996-11-25 | 1996-11-25 | PROCEDURE FOR THE EXPRESSION OF GENES OF DENGUE VIRUSES IN PICHIA PASTORIS LEAVE, RECOMBINANT ADNS AND TRANSFORMED MICROORGANISMS |
AU53973/98A AU5397398A (en) | 1996-11-25 | 1997-11-25 | Process for the expression of genes of the dengue viruses |
BR9713540-2A BR9713540A (en) | 1996-11-25 | 1997-11-25 | Procedure for the expression of the dengue virus gene |
CN97181246A CN1258317A (en) | 1996-11-25 | 1997-11-25 | Process for expression of genes of dengue viruses |
PCT/CU1997/000006 WO1998023754A1 (en) | 1996-11-25 | 1997-11-25 | Process for the expression of genes of the dengue viruses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU1996107A CU22666A1 (en) | 1996-11-25 | 1996-11-25 | PROCEDURE FOR THE EXPRESSION OF GENES OF DENGUE VIRUSES IN PICHIA PASTORIS LEAVE, RECOMBINANT ADNS AND TRANSFORMED MICROORGANISMS |
Publications (1)
Publication Number | Publication Date |
---|---|
CU22666A1 true CU22666A1 (en) | 2001-04-27 |
Family
ID=46093346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU1996107A CU22666A1 (en) | 1996-11-25 | 1996-11-25 | PROCEDURE FOR THE EXPRESSION OF GENES OF DENGUE VIRUSES IN PICHIA PASTORIS LEAVE, RECOMBINANT ADNS AND TRANSFORMED MICROORGANISMS |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN1258317A (en) |
AU (1) | AU5397398A (en) |
BR (1) | BR9713540A (en) |
CU (1) | CU22666A1 (en) |
WO (1) | WO1998023754A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU23245A1 (en) | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CHEMICAL CODING CHAINS FOR INDUCTIVE PROTEINS OF VIRUS EFFECTS. PREPARED USING CHEMICAL PROTEINS |
EP1456230A2 (en) * | 2001-12-04 | 2004-09-15 | Bavarian Nordic A/S | Flavivirus ns1 subunit vaccine |
CU23578A1 (en) | 2005-09-16 | 2010-09-30 | Ct Ingenieria Genetica Biotech | VIRUS CAPSID PROTEIN DENGES INDUCTIVE PROTECTION RESPONSE AND VACCINE COMPOSITION |
CU23586A1 (en) * | 2005-11-22 | 2010-10-30 | Ct Ingenieria Genetica Biotech | METHODS AND PROTEINS FOR THE PROPHLACTIC AND / OR THERAPEUTIC TREATMENT OF THE FOUR SEROTYPES OF THE DENGUE VIRUS AND OTHER FLAVIVIRUS |
CU23630A1 (en) | 2006-10-30 | 2011-02-24 | Ct Ingenieria Genetica Biotech | CHEMERIC PEPTIDE MOLECULES WITH ANTIVIRAL PROPERTIES AGAINST VIRUSES OF THE FLAVIVIRIDAE FAMILY |
CN102363751A (en) * | 2011-03-24 | 2012-02-29 | 中山大学 | Dengue virus (DENV)-like particle as well as preparation method and application thereof |
CN103103293B (en) * | 2013-02-01 | 2014-04-16 | 中华人民共和国北京出入境检验检疫局 | Dengue 2 virus nano-magnetic separation real-time fluorescent quantitative PCR (polymerase chain reaction) test kit and nucleotide sequence |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996037221A1 (en) * | 1995-05-24 | 1996-11-28 | Hawaii Biotechnology Group, Inc. | Subunit vaccine against flavivirus infection |
-
1996
- 1996-11-25 CU CU1996107A patent/CU22666A1/en unknown
-
1997
- 1997-11-25 CN CN97181246A patent/CN1258317A/en active Pending
- 1997-11-25 AU AU53973/98A patent/AU5397398A/en not_active Abandoned
- 1997-11-25 WO PCT/CU1997/000006 patent/WO1998023754A1/en active Application Filing
- 1997-11-25 BR BR9713540-2A patent/BR9713540A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR9713540A (en) | 2000-10-24 |
AU5397398A (en) | 1998-06-22 |
CN1258317A (en) | 2000-06-28 |
WO1998023754A1 (en) | 1998-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK289688A (en) | EXPRESSION OF PROAPOLIPOPROTEIN A-I. | |
ES2059354T3 (en) | A METHOD TO PRODUCE A POLYPEPTIDE. | |
CY1115749T1 (en) | SWINE CYCLE, NUCLEAR ACIDS, POLYPALPTES AND VACCINES | |
DK0484787T3 (en) | HCV-specific peptides, method of obtaining them and their use | |
DK1129190T3 (en) | Human TSLP DNA and polypeptides | |
ATE97164T1 (en) | RECOMBINANT VACCINIA VIRUS MVA. | |
BR9712556A (en) | Plasmid, pharmaceutical composition, and, process of immunizing an individual against an antigen | |
CU22666A1 (en) | PROCEDURE FOR THE EXPRESSION OF GENES OF DENGUE VIRUSES IN PICHIA PASTORIS LEAVE, RECOMBINANT ADNS AND TRANSFORMED MICROORGANISMS | |
DK0909323T3 (en) | Helicobacter pylori bacterioferritin | |
DK0727483T3 (en) | Retrovirus from the HIV group and its use | |
DK1151079T3 (en) | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase and methods of use | |
DE69836520D1 (en) | Clostridium perfringens vaccine | |
PE20000759A1 (en) | CYTOCHROME HYDROQUINONE OXIDASE GENE OF TYPE BD | |
ATE246002T1 (en) | MEMBRANE PROTEINS OF LEPTOSPIRA | |
PE20001331A1 (en) | IDENTIFICATION OF SENV GENOTYPES | |
AR248047A1 (en) | Vaccines based on modified bovine herpesvirus type i | |
BR9915160A (en) | Method to control gene expression in bacteria, namely rhizobiaceae, to improve root nodule development, nitrogen fixation and plant biomass production | |
NO20021851L (en) | <Beta> barrel of lipid substance lipoxygenase | |
BR0318026A (en) | Recombinant Hepatitis Virus Antigens,, and, Use of Antigens | |
KR960041360A (en) | Mass production method of VP2 protein of porcine parvovirus and preparation method of vaccine for porcine parvovirus infection | |
TH34251A (en) | Method for causing Chinese expression of dengue virus |